Oxford Nanopore Technologies (LON:ONT) Downgraded by Citigroup to Buy

Posted by ABMN Staff on Jul 11th, 2026

Citigroup downgraded shares of Oxford Nanopore Technologies (LON:ONT – Free Report) to a buy rating in a research report report published on Friday morning, Marketbeat reports.

Separately, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 225 price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, May 26th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 218.60.

Check Out Our Latest Stock Analysis on ONT

Oxford Nanopore Technologies Price Performance

LON ONT opened at GBX 120.30 on Friday. The stock has a 50-day simple moving average of GBX 123.34 and a 200 day simple moving average of GBX 128.12. Oxford Nanopore Technologies has a twelve month low of GBX 104 and a twelve month high of GBX 224.80. The stock has a market capitalization of £1.17 billion, a PE ratio of -7.97 and a beta of 0.92. The company has a debt-to-equity ratio of 8.96, a quick ratio of 6.01 and a current ratio of 3.56.

Insider Buying and Selling

In related news, insider Nick Keher purchased 22,018 shares of the stock in a transaction on Monday, May 11th. The shares were purchased at an average cost of GBX 113 per share, for a total transaction of £24,880.34. Over the last quarter, insiders acquired 22,799 shares of company stock valued at $2,578,133. 2.54% of the stock is owned by insiders.

Oxford Nanopore Technologies Company Profile

(Get Free Report)

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.